Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
23,109 total articles
Palantir Technologies climbed 4.5% in morning trading after investor Michael Burry disclosed that he closed half of his short position. The move removed a visible overhang on the stock and coincided with new commercial agreements, including a seven-year tie-up with Zeta Global and a potential up-to-$12 million deployment with Surf Air Mobility and …
Eli Lilly shares climbed sharply after the European Medicines Agency’s CHMP issued a favorable opinion for Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia and the company published Medicare GLP-1 Bridge Program guidance that would allow eligible Medicare Part D patients access to Zepbound and Foundayo for $50 per month. An analyst price-ta…
Netflix shares climbed about 5.0% in morning trading after tumbling to a new 52-week low in the prior session. The rebound reflects value-driven buying, supportive analyst commentary, and recent content and distribution agreements, even as the company faces lingering concerns about revenue guidance and its share of streaming time. Q2 2026 results d…
ServiceNow stock rose 6.8% in morning trading after the company announced a three-way AI partnership with HCLTech and Google Cloud designed to accelerate enterprise AI agents from pilot projects into production across field services, manufacturing, customer experience and IT operations. The deal bolsters ServiceNow's growing list of AI collaborator…
Microsoft shares climbed about 4.0% in morning trading, recovering from a 52-week low hit the prior session as value-oriented investors purchased the stock following a sharp pullback. The drop had been triggered by EU regulatory scrutiny of Azure under the Digital Markets Act and ongoing concerns about AI infrastructure costs. Analysts largely pres…
Nextpower Inc (NASDAQ:NXT) shares declined 4.2% on Friday after Jefferies reduced its price target to $153 from $159 while retaining a Buy rating. Jefferies analyst Julian Dumoulin-Smith cited a negative market reaction to the company's latest mergers and acquisitions and growing investor questions about strategic direction. Despite the lower price…
A Jefferies survey of 40 IT executives found Microsoft, Amazon Web Services, Palo Alto Networks and ServiceNow to be the most favored software and services providers heading into 2026. The report also highlights accelerating software budget expectations, widespread dedicated AI budgets and a notably negative read-through for Adobe amid AI-related p…
Incyte Corporation stock rose after the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending approval of Opzelura (ruxolitinib) cream for adults with moderate atopic dermatitis when topical corticosteroids and topical calcineurin inhibitors are inadequate or inappropriate. The recommendat…
HIVE Digital Technologies Ltd. expanded a previously announced exchangeable note offering to $115 million from $100 million, priced through a subsidiary as 0% exchangeable senior notes due 2031. The move coincided with a 3.3% decline in the company’s shares on the announcement date. The notes are exchangeable into common shares at a rate equivalent…
Rocket Lab Corp. shares jumped after NASA selected the company to perform three Electron rocket launches for two science missions - PolSIR and TSIS-2 - planned to begin in early 2027. The award, part of NASA's Venture-Class Acquisition of Dedicated and Rideshare contract with a maximum aggregate value of $300 million, pushed RKLB higher in after-ho…
Aevex Corp. (NYSE: AVEX) saw its shares climb 8.4% on Friday after the company announced it will be added to the Russell 2000 Index as part of the annual reconstitution, effective after the U.S. market opens on June 29, 2026. The listing will also place Aevex in the Russell growth and value style indexes and other related size and sector indexes th…
Argus Research has begun covering Space Exploration Technologies with a Hold rating, warning that the company's unprecedented initial public offering valuation will likely require years to reconcile with more typical market multiples. While SpaceX shows robust top-line growth, the firm’s lofty price-to-sales ratio and uneven profitability profile u…
Can-Fite BioPharma saw its stock climb after Japanese authorities allowed a patent application for the use of Namodenoson and related A3 adenosine receptor agonists to induce fat loss and treat obesity and metabolic disorders. The decision adds to an existing portfolio of granted patents in several countries and is supported by published scientific…
Berkeley Group Holdings PLC shares fell sharply after Berenberg reduced its rating from buy to hold, citing narrowed valuation advantage and a weaker sector outlook. The downgrade followed Berkeley’s FY2026 results and came amid the company’s demotion from the FTSE 100 to the FTSE 250. Broader market headwinds for UK housebuilders - including highe…
Canadian equities were poised for a weaker start on Friday as renewed pressure on global technology names and a sharp drop in crude oil curtailed risk appetite. U.S. futures fell following reports that OpenAI could postpone its IPO, while gold found limited support after several weeks of declines and oil tumbled amid easing supply concerns around t…
Volkswagen is reportedly evaluating the possible shutdown of four production sites in Germany - Emden, Hanover, Zwickau and Audi’s Neckarsulm - in a move that could endanger more than 45,000 positions in addition to the roughly 50,000 job reductions the company agreed with unions in late 2024. The sites vary in size, product focus and recent invest…
Amazon Web Services will increase hourly prices for EC2 Capacity Block reservations for several Nvidia-powered GPU instance families by roughly 20% effective July 1, 2026. The change affects top-tier P6 and P5 families and follows strong cloud revenue growth and heavy capital commitments to AI infrastructure. Enterprises using reserved capacity fac…
Quantum Corp. (NASDAQ:QMCO) experienced an intraday pullback after Northland cut its rating to Market Perform from Outperform while leaving its $13.00 price target unchanged. The downgrade follows a notable run-up in the stock from roughly $7 a share at the time of Northland's November 2025 upgrade to about $13 today. Northland analyst Nehal Choksh…
Altria Group shares ticked up 1% after the U.S. Food and Drug Administration unveiled a proposed rule that would require foreign tobacco manufacturers selling in the United States to register their establishments and list products. The proposal aims to close a regulatory gap, enhance the agency's ability to identify illicit imports - including yout…
Crocs jumped in pre-market trading after Piper Sandler upgraded the stock from Neutral to Overweight and lifted its price target from $95 to $150. The upgrade followed a solid first-quarter 2026 report that beat earnings and revenue estimates and included a raised full-year outlook. Company-specific optimism, including confidence in North American …
Bosch on Friday said Christian Fischer, currently deputy chief executive, will assume the role of chief executive on July 1. The move follows Stefan Hartung's request to leave the board of management after consultations with shareholders. The transition comes as the automotive supplier sector faces high costs, weak demand and geopolitical tensions …
A review of Thursday’s most notable insider transactions across U.S. equities shows a sizable buy by Prospect Capital’s CEO, additional purchases by several energy and fintech executives, and large planned sales at Kymera Therapeutics and Dollar Tree. The filings illustrate contrasting insider approaches - accumulation at companies trading near low…
Omeros Corporation's stock dropped sharply in premarket trading after the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) issued a negative opinion on the company's application to market narsoplimab for hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA). The company said it will reque…
TD Cowen has reiterated its conviction in Axsome Therapeutics by including the biotech in its 'Best Smidcap Ideas 2026' list and boosting its price target to $300 from $275. The firm maintained a buy rating, pointing to momentum behind Auvelity's launch in Alzheimer’s disease agitation, continued growth in major depressive disorder, and a late-stag…
XCharge Ltd ADR (NASDAQ:XCH) saw its shares tumble in premarket trading after the company announced a registered direct offering to a single institutional investor. The sale of 7 million American depositary shares is expected to produce roughly $4.375 million in gross proceeds before placement agent fees and other expenses, and is slated to close o…
